BridgeMD
New treatment option for Alzheimer Disease
Official title Memory for Music: Individual Intensive Musical Training in Alzheimer's Disease
ClinicalTrials.gov ID: NCT06611878
What this study is testing
- What it's testing
- This project, called Memory for Music, focuses on the increasing number of people worldwide living with dementia, especially Alzheimer's disease (AD). AD typically starts with memory problems and eventually affects daily activities.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Diagnosis of Alzheimer's disease
- Home-dwelling
- Non-musician
You likely can't join if
- Non-Alzheimer dementia
- Living in care home
- History as a professional musician
The study team makes the final eligibility decision.
Where it's taking place
- Buenos Aires, Argentina
- Vienna, Austria
- Bergen, Vestland, Norway
- Florø, Norway
- Oslo, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Buenos Aires, Argentina; Vienna, Austria; Bergen, Vestland, Norway; Florø, Norway; Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.